Plasma from recovered patients may help treat COVID-19

The transcript discusses the use of plasma from recovered COVID-19 patients to treat critically ill individuals. A state-owned pharmaceutical company claims significant patient improvement within 12 to 24 hours, citing reduced inflammation and improved blood oxygen levels. An unnamed expert highlights the presence of special antibodies in the plasma. The treatment was tested successfully in over 10 patients, and it is considered the best option for reducing mortality rates. The president of Wuhan Jinyin Town Hospital has called for plasma donations.

What does the group claim about the treatment's effect on patients' conditions?

What specific improvements does the treatment reportedly lead to after 12 to 24 hours?

What type of antibodies does the plasma contain according to the group?

How many patients was the procedure successfully tested on?

What did the president of Wuhan Jinyin Town Hospital call for on February 13th?